What is Generative Optogenetics?
Synthetic DNA and RNA molecules are foundational to a host of next-generation technologies crucial for national security and global well-being, impacting everything from resilient supply chains and advanced materials manufacturing to sustainable agriculture and human health. However, current methods for creating these molecules de novo face significant limitations in terms of scale, complexity, and environmental impact.
The Generative Optogenetics (GO) program seeks to overcome these challenges by pioneering a revolutionary approach: Harnessing the power of light to direct the synthesis of DNA and RNA directly within living cells.
If successful, this high-risk, high-reward research program promises to revolutionize medicine, agriculture, and manufacturing by enabling a new era of bioprogramming.
Related content
Opportunities
DARPA-SN-26-27
Overview
If successful, this high-risk, high-reward research program promises to revolutionize medicine, agriculture, and manufacturing by enabling a new era of bioprogramming. | 1:47
Program Manager Mathew Pava explains how we are revolutionizing medicine, agriculture, and manufacturing with light-powered biology. | 29:45
Instructions
Interested in being a part of this program? Contracting Officer Belinda Nwanguma gives a demo of the cost proposal spreadsheet. | 10:09
Overview of Fundamental Research Risk-Based Security Review and CUI with Program Security Officer John Slawinski. | 7:13